CrushSCI.com
137.6Average days
123Median days
34Fastest days
416Longest days
2392025 publications

Paper Review Records

All Paper Review Records

29 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

60 days

Recent Developments in Sulfonafmide‐Based Anti‐Malarial Agents: Structure–Activity Relationships and Future Perspectives

Authors
Shu‐Hui Kong; Sohilkhan Chauhan; Sandhya Patre; Rakesh Kumar Kurre; Kadalipura P. Rakesh; Hua‐Li QinShow moreShow less
Affiliations
1. School of Chemistry, Chemical Engineering and Life Sciences Wuhan University of Technology Wuhan People's Republic of China; 2. Department of Chemistry, Faculty of Science Gokul Global University Sidhpur Gujarat India; 3. Department of Chemistry Sant Shiromani Guru Ravidas Govt. College Sargoan Chhattisgarh India; 4. Department of Physics Govt. J.M.P. College Takhatpur Chhattisgarh IndiaShow moreShow less
Source PDF DOI Publisher page
57 days

Roflumilast and Melatonin Alleviate Acetic Acid‐Induced Ulcerative Colitis via Modulating AMPK/mTOR Signaling, Autophagy‐Related Markers, Intestinal Epithelial Barrier, and NLRP3 Inflammasome

Authors
Mohamed I. EL‐Sharkawi; Sousou I. Ali; Mohamed A. Shaheen; Rana G. EissaShow moreShow less
Affiliations
1. Department of Biochemistry, Faculty of Pharmacy Zagazig University Zagazig Egypt; 2. Department of Histology & Cell Biology, Faculty of Medicine Zagazig University Zagazig EgyptShow moreShow less
Source PDF DOI Publisher page
101 days

Ataxia Telangiectasia and Rad3‐Related Kinase as a Drug Target and Its Inhibitors: Synthetic Aspects, Current Research and Potential Perspectives

Authors
Pranav Bhagwat; Sivapriya KirubakaranShow moreShow less
Affiliations
1. Department of Chemistry Indian Institute of Technology Gandhinagar Gandhinagar Gujarat IndiaShow moreShow less
Source PDF DOI Publisher page
307 days

Exploring Key Microbial Enzymes as Targets for Benzimidazole Derivatives: Synthesis, SAR, and Therapeutic Relevance

Authors
Geeta Yadav; Rahul Jain; Yugal KumarShow moreShow less
Affiliations
1. School of Pharmaceutical Sciences CGC University Mohali Punjab India; 2. Department of Medicinal Chemistry National Institute of Pharmaceutical Education and Research (NIPER) Punjab India; 3. Department of Computer Engineering, School of Technology Management and Engineering, NMIMS, Chandigarh Campus Chandigarh IndiaShow moreShow less
Source PDF DOI Publisher page
219 days

Towards Greener Pastures in Alzheimer's Therapy: Synthesis and XRD/HSA/DFT Mechanistic Investigation of Novel Trifluoromethylated Compounds

Authors
Musa A. Said; Nadia S. Al‐Kaff; David L. Hughes; Biprajit SarkarShow moreShow less
Affiliations
1. Department of Chemistry, Faculty of Science Islamic University of Madinah Madinah Saudi Arabia; 2. Department of Biology, Faculty of Science Taibah University Al‐Madinah Al‐Monawara Saudi Arabia; 3. School of Chemistry University of East Anglia Norwich UK; 4. Institut für Chemie und Biochemie, Anorganische Chemie Freie Universität Berlin Berlin GermanyShow moreShow less
Source PDF DOI Publisher page
109 days

Design, Synthesis, Structure and Biological Activity of New Five‐Membered Heterocyclic Systems Based on 2,7‐Naphthyridines: A New Class of Psychotropic Compounds

Authors
Samvel N. Sirakanyan; Anush A. Hovakimyan; Anthi Petrou; Maria Fesatidou; Athina Geronikaki; Victor G. Kartsev; Hasmik A. Yegoryan; Hasmik V. Jughetsyan; Mariam E. Manukyan; Armen G. Ayvazyan; Ruzanna G. Paronikyan; Tatevik A. Araqelyan; Elmira K. HakobyanShow moreShow less
Affiliations
1. Scientific Technological Center of Organic and Pharmaceutical Chemistry Institute of Fine Organic Chemistry of A. L. Mnjoyan Yerevan Republic of Armenia; 2. School of Pharmacy Aristotle University of Thessaloniki Thessaloniki Greece; 3. InterBioScreen Moscow Russia; 4. Scientific Technological Center of Organic and Pharmaceutical Chemistry, Molecule Structure Research Center Yerevan Republic of ArmeniaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does ARCHIV DER PHARMAZIE take to review a manuscript?

As of 2026-11-17, CrushSCI has 29 complete review records for ARCHIV DER PHARMAZIE. The fastest paper went from submission to acceptance in 34 days (Evaluation of Novel Cloxyquin Analogs for K 2P 18.1 Channel Modulation, received 2026-06-03, accepted 2026-07-07); the slowest took 416 days. The average is 137.6 days and the median is 123 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.